236 related articles for article (PubMed ID: 22492871)
1. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
2. Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.
Panda H; Pelakh L; Chuang TD; Luo X; Bukulmez O; Chegini N
Reprod Sci; 2012 Aug; 19(8):786-96. PubMed ID: 22569286
[TBL] [Abstract][Full Text] [Related]
3. Effects of estradiol, progesterone or cAMP on expression of PGRMC1 and progesterone receptor in a xenograft model of human endometrium and in endometrial cell culture.
Van Wynendaele M; Thieffry C; Samain L; Pierreux CE; Tyteca D; Marbaix E; Henriet P
Steroids; 2023 Oct; 198():109284. PubMed ID: 37487815
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
[TBL] [Abstract][Full Text] [Related]
5. miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis.
Zhou M; Fu J; Xiao L; Yang S; Song Y; Zhang X; Feng X; Sun H; Xu W; Huang W
Hum Reprod; 2016 Nov; 31(11):2598-2608. PubMed ID: 27619769
[TBL] [Abstract][Full Text] [Related]
6. Micro-RNA-181a suppresses progestin-promoted breast cancer cell growth.
Gu M; Wang L; Yang C; Li X; Jia C; Croteau S; Ruan X; Hardy P
Maturitas; 2018 Aug; 114():60-66. PubMed ID: 29907248
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis.
Bali N; Arimoto JM; Iwata N; Lin SW; Zhao L; Brinton RD; Morgan TE; Finch CE
Endocrinology; 2012 Feb; 153(2):759-69. PubMed ID: 22147012
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
10. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients.
Geletina NS; Kobelev VS; Babayants EV; Feng L; Pustylnyak VO; Gulyaeva LF
Gene; 2018 May; 655():20-24. PubMed ID: 29477866
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis.
Anupa G; Sharma JB; Roy KK; Sengupta J; Ghosh D
Reprod Biol Endocrinol; 2019 Dec; 17(1):111. PubMed ID: 31878927
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Role of PGRMC1 During Human Decidualization Using an In Vitro Approach.
Salsano S; González-Martín R; Quiñonero A; Pérez-Debén S; Domínguez F
J Clin Endocrinol Metab; 2021 Jul; 106(8):2313-2327. PubMed ID: 33955452
[TBL] [Abstract][Full Text] [Related]
13. Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis.
Keator CS; Mah K; Slayden OD
Mol Hum Reprod; 2012 Jun; 18(6):308-19. PubMed ID: 22307145
[TBL] [Abstract][Full Text] [Related]
14. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
Sueldo C; Liu X; Peluso JJ
Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
16. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
17. [Differential expression of microRNA in eutopic endometrium tissue during implantation window for patients with endometriosis related infertility].
Wang Y; Ma CH; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):436-41. PubMed ID: 27356479
[TBL] [Abstract][Full Text] [Related]
18. Association between progesterone and estradiol-17beta treatment and protein expression of pgr and PGRMC1 in porcine luminal epithelial cells: a real-time cell proliferation approach.
Kempisty B; Wojtanowicz-Markiewicz K; Ziółkowska A; Budna J; Ciesiółka S; Piotrowska H; Bryja A; Antosik P; Bukowska D; Wollenhaupt K; Bruska M; Brüssow KP; Nowicki M; Zabel M
J Biol Regul Homeost Agents; 2015; 29(1):39-50. PubMed ID: 25864740
[TBL] [Abstract][Full Text] [Related]
19. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
20. Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.
Wendler A; Keller D; Albrecht C; Peluso JJ; Wehling M
Oncol Rep; 2011 Jan; 25(1):273-9. PubMed ID: 21109987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
